vs
Side-by-side financial comparison of HARROW, INC. (HROW) and LandBridge Co LLC (LB). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $56.8M, roughly 1.6× LandBridge Co LLC). LandBridge Co LLC runs the higher net margin — 14.2% vs 7.4%, a 6.7% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs 33.3%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $8.1M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs 60.5%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
HROW vs LB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $56.8M |
| Net Profit | $6.6M | $8.1M |
| Gross Margin | 79.3% | — |
| Operating Margin | 17.5% | 60.0% |
| Net Margin | 7.4% | 14.2% |
| Revenue YoY | 33.3% | 55.6% |
| Net Profit YoY | -2.2% | -83.7% |
| EPS (diluted) | $0.20 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $56.8M | ||
| Q3 25 | $71.6M | $50.8M | ||
| Q2 25 | $63.7M | $47.5M | ||
| Q1 25 | $47.8M | $44.0M | ||
| Q4 24 | $66.8M | $36.5M | ||
| Q3 24 | $49.3M | $28.5M | ||
| Q2 24 | $48.9M | $26.0M | ||
| Q1 24 | $34.6M | $19.0M |
| Q4 25 | $6.6M | $8.1M | ||
| Q3 25 | $1.0M | $8.1M | ||
| Q2 25 | $5.0M | $7.5M | ||
| Q1 25 | $-17.8M | $6.5M | ||
| Q4 24 | $6.8M | $49.3M | ||
| Q3 24 | $-4.2M | $2.7M | ||
| Q2 24 | $-6.5M | $-57.7M | ||
| Q1 24 | $-13.6M | $10.8M |
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
| Q4 25 | 17.5% | 60.0% | ||
| Q3 25 | 20.6% | 60.8% | ||
| Q2 25 | 17.9% | 60.0% | ||
| Q1 25 | -23.5% | 57.0% | ||
| Q4 24 | 19.3% | 49.4% | ||
| Q3 24 | 2.7% | 11.2% | ||
| Q2 24 | 3.1% | -197.4% | ||
| Q1 24 | -20.0% | 71.1% |
| Q4 25 | 7.4% | 14.2% | ||
| Q3 25 | 1.4% | 15.9% | ||
| Q2 25 | 7.8% | 15.8% | ||
| Q1 25 | -37.2% | 14.7% | ||
| Q4 24 | 10.1% | 135.2% | ||
| Q3 24 | -8.6% | 9.3% | ||
| Q2 24 | -13.2% | -222.1% | ||
| Q1 24 | -39.2% | 56.7% |
| Q4 25 | $0.20 | $0.24 | ||
| Q3 25 | $0.03 | $0.26 | ||
| Q2 25 | $0.13 | $0.24 | ||
| Q1 25 | $-0.50 | $0.20 | ||
| Q4 24 | $0.19 | — | ||
| Q3 24 | $-0.12 | $-0.04 | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $-0.38 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $30.7M |
| Total DebtLower is stronger | $250.0M | $570.7M |
| Stockholders' EquityBook value | $52.4M | $340.3M |
| Total Assets | $399.5M | $1.4B |
| Debt / EquityLower = less leverage | 4.77× | 1.68× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $30.7M | ||
| Q3 25 | $74.3M | $28.3M | ||
| Q2 25 | $53.0M | $20.3M | ||
| Q1 25 | $66.7M | $14.9M | ||
| Q4 24 | $47.2M | $37.0M | ||
| Q3 24 | $72.6M | $14.4M | ||
| Q2 24 | $71.0M | $24.6M | ||
| Q1 24 | $76.0M | — |
| Q4 25 | $250.0M | $570.7M | ||
| Q3 25 | $347.2M | $366.1M | ||
| Q2 25 | $250.6M | $370.9M | ||
| Q1 25 | $256.9M | $375.5M | ||
| Q4 24 | $262.7M | $385.5M | ||
| Q3 24 | $230.7M | $242.4M | ||
| Q2 24 | $236.3M | $360.8M | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $340.3M | ||
| Q3 25 | $47.0M | $272.0M | ||
| Q2 25 | $49.7M | $266.4M | ||
| Q1 25 | $56.5M | $217.0M | ||
| Q4 24 | $69.7M | $211.8M | ||
| Q3 24 | $58.0M | $97.2M | ||
| Q2 24 | $58.5M | $296.4M | ||
| Q1 24 | $60.6M | $162.3M |
| Q4 25 | $399.5M | $1.4B | ||
| Q3 25 | $363.1M | $1.1B | ||
| Q2 25 | $345.0M | $1.1B | ||
| Q1 25 | $364.2M | $1.0B | ||
| Q4 24 | $389.0M | $1.0B | ||
| Q3 24 | $351.5M | $689.9M | ||
| Q2 24 | $306.6M | $710.5M | ||
| Q1 24 | $295.5M | — |
| Q4 25 | 4.77× | 1.68× | ||
| Q3 25 | 7.39× | 1.35× | ||
| Q2 25 | 5.05× | 1.39× | ||
| Q1 25 | 4.55× | 1.73× | ||
| Q4 24 | 3.77× | 1.82× | ||
| Q3 24 | 3.98× | 2.49× | ||
| Q2 24 | 4.04× | 1.22× | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $126.3M |
| Free Cash FlowOCF − Capex | $8.1M | $122.0M |
| FCF MarginFCF / Revenue | 9.1% | 214.9% |
| Capex IntensityCapex / Revenue | 0.4% | 7.5% |
| Cash ConversionOCF / Net Profit | 1.27× | 15.68× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $207.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $126.3M | ||
| Q3 25 | $16.6M | $34.9M | ||
| Q2 25 | $-803.0K | $37.3M | ||
| Q1 25 | $19.7M | $15.9M | ||
| Q4 24 | $-17.8M | $67.6M | ||
| Q3 24 | $3.0M | $7.5M | ||
| Q2 24 | $-2.7M | $16.0M | ||
| Q1 24 | $-4.6M | $17.2M |
| Q4 25 | $8.1M | $122.0M | ||
| Q3 25 | $16.4M | $33.7M | ||
| Q2 25 | $-969.0K | $36.1M | ||
| Q1 25 | $19.5M | $15.8M | ||
| Q4 24 | $-18.3M | $66.7M | ||
| Q3 24 | $2.3M | $7.1M | ||
| Q2 24 | $-3.1M | $15.7M | ||
| Q1 24 | $-4.7M | $17.1M |
| Q4 25 | 9.1% | 214.9% | ||
| Q3 25 | 22.9% | 66.3% | ||
| Q2 25 | -1.5% | 75.9% | ||
| Q1 25 | 40.8% | 36.0% | ||
| Q4 24 | -27.4% | 182.6% | ||
| Q3 24 | 4.8% | 25.1% | ||
| Q2 24 | -6.3% | 60.4% | ||
| Q1 24 | -13.6% | 90.1% |
| Q4 25 | 0.4% | 7.5% | ||
| Q3 25 | 0.3% | 2.3% | ||
| Q2 25 | 0.3% | 2.6% | ||
| Q1 25 | 0.4% | 0.2% | ||
| Q4 24 | 0.8% | 2.7% | ||
| Q3 24 | 1.2% | 1.1% | ||
| Q2 24 | 0.7% | 1.4% | ||
| Q1 24 | 0.3% | 0.5% |
| Q4 25 | 1.27× | 15.68× | ||
| Q3 25 | 16.26× | 4.31× | ||
| Q2 25 | -0.16× | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | -2.62× | 1.37× | ||
| Q3 24 | — | 2.80× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
